View Future GrowthIntelligene 과거 순이익 실적과거 기준 점검 0/6Intelligene 의 수입은 연평균 -4.5%의 비율로 감소해 온 반면, Biotechs 산업은 연평균 21.8%의 비율로 증가했습니다. 매출은 연평균 49%의 비율로 감소해 왔습니다.핵심 정보-4.55%순이익 성장률12.53%주당순이익(EPS) 성장률Biotechs 산업 성장률12.22%매출 성장률-48.99%자기자본이익률-16.17%순이익률-6,223.37%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Apr 06Full year 2025 earnings released: NT$0.26 loss per share (vs NT$0.30 loss in FY 2024)Full year 2025 results: NT$0.26 loss per share. Net loss: NT$148.6m (loss widened 4.5% from FY 2024).모든 업데이트 보기Recent updatesReported Earnings • Apr 06Full year 2025 earnings released: NT$0.26 loss per share (vs NT$0.30 loss in FY 2024)Full year 2025 results: NT$0.26 loss per share. Net loss: NT$148.6m (loss widened 4.5% from FY 2024).공고 • Mar 23Intelligene Inc., Annual General Meeting, Jun 08, 2026Intelligene Inc., Annual General Meeting, Jun 08, 2026, at 10:00 Taipei Standard Time. Location: 1 floor no,508, sec.7 chung hsiao e. rd., nangang district, taipei city TaiwanNew Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change).New Risk • Feb 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k).New Risk • Nov 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.7% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k). Minor Risk Less than 3 years of financial data is available.New Risk • Oct 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$109k). Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (7.1% average weekly change).New Risk • Aug 31New major risk - Revenue and earnings growthRevenue has declined by 13% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$110k). Minor Risk Less than 3 years of financial data is available.매출 및 비용 세부 내역Intelligene가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TPEX:7832 매출, 비용 및 순이익 (TWD Millions)날짜매출순이익일반관리비연구개발비31 Dec 252-1494410930 Sep 253-1584310030 Jun 253-167419131 Mar 254-154598231 Dec 245-142767231 Dec 233-342411양질의 수익: 7832 은(는) 현재 수익성이 없습니다.이익 마진 증가: 7832는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 지난 5년 동안 7832의 연간 수익 성장률이 양(+)이었는지 판단하기에 데이터가 부족합니다.성장 가속화: 현재 수익성이 없어 지난 1년간 7832의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 7832은 수익성이 없어 지난 해 수익 성장률을 Biotechs 업계(18.9%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 7832는 현재 수익성이 없으므로 자본 수익률이 음수(-16.17%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/11 22:29종가2026/08/11 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Intelligene Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Apr 06Full year 2025 earnings released: NT$0.26 loss per share (vs NT$0.30 loss in FY 2024)Full year 2025 results: NT$0.26 loss per share. Net loss: NT$148.6m (loss widened 4.5% from FY 2024).
Reported Earnings • Apr 06Full year 2025 earnings released: NT$0.26 loss per share (vs NT$0.30 loss in FY 2024)Full year 2025 results: NT$0.26 loss per share. Net loss: NT$148.6m (loss widened 4.5% from FY 2024).
공고 • Mar 23Intelligene Inc., Annual General Meeting, Jun 08, 2026Intelligene Inc., Annual General Meeting, Jun 08, 2026, at 10:00 Taipei Standard Time. Location: 1 floor no,508, sec.7 chung hsiao e. rd., nangang district, taipei city Taiwan
New Risk • Mar 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.4% average weekly change).
New Risk • Feb 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k).
New Risk • Nov 28New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.7% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$107k). Minor Risk Less than 3 years of financial data is available.
New Risk • Oct 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$109k). Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (7.1% average weekly change).
New Risk • Aug 31New major risk - Revenue and earnings growthRevenue has declined by 13% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.9% average weekly change). Revenue has declined by 13% over the past year. Revenue is less than US$1m (NT$3.4m revenue, or US$110k). Minor Risk Less than 3 years of financial data is available.